Immunocore Holdings plc (IMCR) has a PEG ratio of 192.59, above the Healthcare sector average of 3.22.
Get informed when a big investor buys or sells
+ Follow192.59
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Immunocore Holdings plc's peg ratio stands at 192.59. That is above the Healthcare sector average of 3.22. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Immunocore Holdings plc sits higher the Healthcare benchmark (3.22) with a PEG ratio of 192.59. That is roughly 5876.3% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 192.59 is attractive depends on Immunocore Holdings plc's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Immunocore Holdings plc's PEG ratio evolved across reporting periods, while the comparison chart places IMCR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, PEG ratio is commonly used to spot outliers. Immunocore Holdings plc's reading of 192.59 (sector avg 3.22) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.